Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
With regards my hypertension, a possible side-effect of my bladder cancer treatment, I have decided that I do need to go back on at least one of my pills. I tried getting by without any of the four I’d taken, hoping that the laser TURP I’d had in August 2014 had dealt with it. Alas, although that seemed OK for a day or so, gradually my blood pressure rose to an unhealthy level – about 170/90 or more. Having done an analysis of my nutrition group and hypertension pills, I found that although sodium/salt, carbs/sugar both showed to significantly increase my blood pressure, reducing these (less than 1gm for sodium, less than 50g for carbs and less than 10g for sugar) only partially helped. So I’m trying the one of the two pills that showed most help, and was recommended for kidney problems – perindopril. The initial results are promising:
The charity Cancer Research UK called the tests an "exciting but very ... this immunotherapy would be at killing cancer cells in the body and improving ...
The vaccine approach seeks to "remind" the patient's immune system that mutated cancer proteins aren't a part of their own bodies, "in a way that will ...
Cancer immunotherapy encompasses a broad range of approaches, including ....Cancer can elude the immune system by suppressing T cells, which ...
A new experimental cancer therapy involving a re-engineered polio virus is ... The polio virus dies very rapidly, but it wakes up the immune system, ...
... vaccine also targets mesothelin but is designed to strengthen a patient's immune system, allowing healthy cells to fight off cancer growth.
While standard chemotherapy drugs damage DNA to stop cancer cells from reproducing, the new method ... SNAs have unique properties that allow them to reach cells safely without causing toxicity or activating the immune system.
| The Hindu |
... the Kerala Agricultural University (KAU) and the Regional Cancer Centre (RCC) ... benefits on the human liver, kidneys, heart, and immune system.
Kerala scientists identify anti-cancer properties in a fungus used for bio-control in agriculture - TheHealthSite
Personalized Cancer Vaccines
As previously observed in other studies of non-personalized dendritic cell vaccines, the level of T-cell immunity seen with fresh, unstimulated blood samples was only slightly higher compared to pre-vaccination blood samples in the study. “The T-cell immunity found in the blood post vaccine was quite modest, so the clinical utility of this [vaccine] is far from clear,” said Weber. In its current state, the procedure is somewhat limited because advanced melanoma patients do not have multiple months to wait on vaccine production
Today, scientists at the Translational Genomics Research Institute (TGen) are using zebrafish to accelerate investigations of pancreatic cancer, the ...
Cancer Research UK scientists have discovered that a vital self-destruct switch in cells is hijacked - making some pancreatic and non small cell lung ...
NEW YORK, April 2, 2015 /PRNewswire/ -- Currently only seven percent of people diagnosed with pancreatic cancer in the United States will survive ...
Pancreatic cancer is one of the most serious types of cancer, with a survival rate of just five years of 5%. It is difficult to detect early on and symptoms ...
Here it was found that laboratory rats developed of bladder cancer when given equivalent quantities of Saccharin that a person could take in a ...
Science Daily Cancer News
The micro RNA miR-22 has long been known for its ability to suppress cancer. However, questions remain about how it achieves this feat. For example, which molecules are regulating miR-22, and which are miR22 targets? Researchers have unraveled some of these relationships, identifying several interactions that directly impact liver and colon cancer.
Scientists have identified a small RNA molecule that can suppress cancer-causing genes in mice with glioblastoma mulitforme, a deadly and incurable type of brain tumor. While standard chemotherapy drugs damage DNA to stop cancer cells from reproducing, the new method stops the source that creates those cancer cells. The approach could also potentially be used for gene silencing in other cancers and diseases of genetic origin.
Recent large-scale genomic analyses have uncovered dozens of common genetic variants that are associated with breast cancer. Each variant, however, contributes only a tiny amount to a person’s overall risk of developing the disease. Now an international team of researchers has combined 77 of these common genetic variants into a single risk factor that can be used to improve the identification of women with an elevated risk of breast cancer. This factor, known as a polygenic risk score, was built from the genetic data of more than 67,000 women.
Spreading the success of cancer immunotherapy beyond those patients currently enjoying powerful, long-term responses to treatment requires greater understanding of the immune response to tumors, two leaders in the field note in a new review.
Researchers found that consuming the fish herring and mackerel, as well as three kinds of fish oils, raised blood levels of the fatty acid 16:4(n-3), which experiments in mice suggest may induce resistance to chemotherapy used to treat cancer.
Tambahkan Komentar